Myasthenia gravis – pipeline review, h1 2012


Published on | Myasthenia Gravis – Pipeline Review, H1 2012 || Market Research

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Myasthenia gravis – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Myasthenia Gravis – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Myasthenia Gravis - Pipeline Review, H1 2012, provides anoverview of the Myasthenia Gravis therapeutic pipeline. This report providesinformation on the therapeutic development for Myasthenia Gravis, complete withlatest updates, and special features on late-stage and discontinued projects. It alsoreviews key players involved in the therapeutic development for Myasthenia Gravis.Myasthenia Gravis - Pipeline Review, H1 2012 is built using data and informationsourced from Global Markets Direct’s proprietary databases, Company/Universitywebsites, SEC filings, investor presentations and featured press releases fromcompany/university sites and industry-specific third party sources, put together byGlobal Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Myasthenia Gravis.- A review of the Myasthenia Gravis products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.
  2. 2. - A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 3List of Figures 3Introduction 4Global Markets Direct Report Coverage 4Dental Plaque Overview 5Therapeutics Development 6An Overview of Pipeline Products for Dental Plaque 6Dental Plaque Therapeutics under Development by Companies 8Dental Plaque Therapeutics under Investigation by Universities/Institutes 9Mid Clinical Stage Products 10Comparative Analysis 10Early Clinical Stage Products 11Comparative Analysis 11Pre-Clinical Stage Products 12Comparative Analysis 12Dental Plaque Therapeutics – Products under Development by Companies 13Dental Plaque Therapeutics – Products under Investigation byUniversities/Institutes 14Companies Involved in Dental Plaque Therapeutics Development 15Aphios Corporation 15Dental Plaque – Therapeutics Assessment 16Assessment by Monotherapy Products 16Assessment by Route of Administration 17Assessment by Molecule Type 19Drug Profiles 21Asterias - Drug Profile 21Product Description 21Mechanism of Action 21R&D Progress 21Chlorhexidine Digluconate - Drug Profile 22
  3. 3. Product Description 22Mechanism of Action 22R&D Progress 22Green Propolis - Drug Profile 23Product Description 23Mechanism of Action 23R&D Progress 23Dental Plaque Therapeutics - Dormant Products 24Appendix 25Methodology 25Coverage 25Secondary Research 25Primary Research 25Expert Panel Validation 25Contact Us 26Disclaimer 26List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Erosive Oral Lichen Planus – Pipeline Review, H1 2012
  4. 4. Pancreatic Cancer – Pipeline Review, H1 2012Metastatic Hormone Refractory Prostate Cancer – Pipeline Review, H1 2012Myasthenia Gravis – Pipeline Review, H1 2012Dental Plaque – Pipeline Review, H1 2012Esophagitis – Pipeline Review, H1 2012Retinitis Pigmentosa (Retinitis) – Pipeline Review, H1 2012Cellulite – Pipeline Review, H1 2012HIV Pain – Pipeline Review, H1 2012Tropical Spastic Paraparesis – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585
  5. 5. Email: